Study Shows Nevirapine A New Treatment Option For HIV-Positive Infants
A new study shows that HIV-positive babies with stabilized infections “will do just fine switching to a regime of nevirapine, a reverse transcriptase inhibitor,” from a more expensive protease inhibitor, Scientific American’s “Observations” blog reports (Harmon, 9/7).